Involvement of some 5-HT receptors in methamphetamine-induced locomotor activity in mice

Journal of Physiology and Pharmacology

Volumn 55, Issue 2, 2004, Pages 357-369

  Ginawi, O T ^a   Al Majed, A A ^a   Al Suwailem, A K ^a   El Hadiyah, T M H ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

5 HT; Locomotor activity; Methamphetamine; Methiothepin; Methysergide; Mianserin; NAN 190; Ondansetron; Serotonin

Indexed keywords

1 (2 METHOXYPHENYL) 4 (4 PHTHALIMIDOBUTYL)PIPERAZINE; METHAMPHETAMINE; METHYSERGIDE; METITEPINE; MIANSERIN; ONDANSETRON; RECEPTOR SUBTYPE; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR; SEROTONIN 1B ANTAGONIST; SEROTONIN 1B RECEPTOR; SEROTONIN 1D ANTAGONIST; SEROTONIN 1D RECEPTOR; SEROTONIN 2 ANTAGONIST; SEROTONIN 2A ANTAGONIST; SEROTONIN 2A RECEPTOR; SEROTONIN 2B ANTAGONIST; SEROTONIN 2B RECEPTOR; SEROTONIN 2C ANTAGONIST; SEROTONIN 2C RECEPTOR; SEROTONIN 3 ANTAGONIST; SEROTONIN 3 RECEPTOR; SEROTONIN RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; HYPERACTIVITY; LOCOMOTION; MALE; MOUSE; NONHUMAN; TIME SERIES ANALYSIS;

ANIMALS; INJECTIONS, INTRAPERITONEAL; MALE; METHAMPHETAMINE; MICE; MOTOR ACTIVITY; PROTEIN SUBUNITS; RECEPTORS, SEROTONIN; SEROTONIN ANTAGONISTS; STEREOTYPED BEHAVIOR;

EID: 3142629992     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Creese I, Iverson SD. Blockade of amphetamine-induced motor stimulation and stereotype in the adult rat following neonatal treatment with 6-hydroxydopamine. Brain Res 1973; 55: 369-382.
2. Kelly PH. GABA stimulation and blockade in the hypothalamus and midbrain: effects on feeding and locomotor activity. Pharmacol Biochem Behav 1977; 6: 537-541.
3. Taglimonte A, Tagliamonte P, Gessa GL. Effect of psychoactive drugs on tryptophan concentration in the rat brain. J Pharmacol Exp Ther 1977; 177: 475-480.
4. Holmes JC, Rutledge CO. Effects of the D-and L-isomers of amphetamine on uptake, release and catabolism of norepinephrine, dopamine, and 5-hydroxytryptamine in several regions of rat brain. Biochem Pharmacol 1976; 25: 447-451.
5. Fuxe K, Ungerstedt U. Histochemical studies on the effect of (positive)-amphetamine, drugs of the imipramine group and tryptamine on central catecholamine and 5-hydroxytryptamine neurons after intraventricular injection of catecholamines and 5-hydroxytryptamine. Eur J Pharmacol 1970; 2: 135-144.
6. Foote WE, Sheard MH, Aghajanian GK. Comparison of effects of LSD and amphetamine on mid-brain raphe units. Nature 1969; 222: 567-569.
7. Hoftman BB: Adrenoceptors-activating and other sympathomimetic drugs. In Basic and Clinical Pharmacology, VIIIth Edition. Edited by Katzung BG. New York: Lange press; 2001; pp. 120-137.
8. Raul R, Gainetdinov R, Mohn M, Marc G. Glutamatergic modulation of hyperactivity in mice lacking the dopamine transporter. Proc Natl Acad Sci 2001; 20: 11047-11054.
9. Aulakh CS, Mazzola-Pomietto P, Wozniak KM, Hill JL, Murphy DL. Evidence that 1-(2, 5-dimethoxy-4-methyl-phenyl)-2-aminopropane-induced hypophagia and hyperthermia in rats is mediated by serotonin-2A receptors. J Pharmacol Exp Ther 1994; 270: 127-132.
10. Costall B, Naylor RJ. Antagonism of the hyperactivity induced by dopamine applied intracerebrally to the nucleus accumbens septi by typical neuroleptics and by clozapine, sulpiride and thioridazine. Eur J Pharmacol. 1976; 35: 161-168.
11. Pijnenburg AJJ, Honig WMM, Van Rossum JM. Effects of antagonists upon locomotor stimulation induced by injection of dopamine and noradrenaline into the nucleus accumbens of nialamide-pretreated rats. Psychopharmacol 1975; 41: 175-180.
12. Steven JR. Schizophrenia and dopamine regulation in the mesolimbic system. Trends Neurosci 1979; 2: 102.
13. Munzar P, Laufert MD. Effects of various serotonin agonists, antagonists, and uptake inhibitors on the discriminative stimulus effects of methamphetamine in rats. J Pharmacol Exp Ther 1999; 291: 239-250.
14. Fibiger HC, Campbell BA. The effect of parachlorophenylalanine on spontaneous locomotor activity in the rat. Neuropharmacol 1971; 10: 25-32.
15. Chrusciel TL, Herman ZS. Effect of dopalanine on behaviour in mice depleted of norepinephrine or serotonin. Psychopharmacol 1969; 14: 124-134.
16. Martin GR, Humphrey PPA. Receptors for 5-hydroxytryptamine: current perspectives on classification and nomenclature. Neuropharmacol 1994; 33: 261-273.
17. Beer MS, Middlemiss DN, McAllister G. 5-HT1-like receptors: six down and still counting. Trends Pharmacol Sci 1993; 14: 228-231.
18. Movahedi H, Purdy RE. Pharmacological characterization of the "silent" 5-hydroxytryptamine 1B-like receptors of rabbit car artery. J Pharmacol Exp Ther 1997; 283: 653-660.
19. Watson JM, Burton MJ, Price GM, Jones BJ, Middlemiss DN. GR127935 acts as a partial agonist at recombinant human 5-HT1D alpha and 5-HT1D beta receptors. Eur J Pharmacol 1996; 314: 365-372.
20. Millan MJ, Colpaert FC. Methylenedioxy methamphetamine induces spontaneous tail-flicks in the rat via 5-HT1A receptors. Eur J Pharmacol 1991; 193: 145-152.
21. Millan MJ, Rivet JM, Canton H, Lemarouille S, Gobert A. Induction of hypothermia as a model of 5-hydroxytryptamine1A receptor-mediated activity in the rat: a pharmacological characterization of the actions of novel agonists and antagonists. J Pharmacol Exp Ther 1993; 264: 1364-1376.
22. Cox B, Ennis C. Characterization of 5-hydroxytryptaminergic autoreceptors in the rat hypothalamus. J Pharm Pharmacol 1982; 34: 438-441.
23. Watson NV, Hargreaves EL, Penava D, Eckel LA, Vanderwolf CH. Serotonin-dependent cerebral activation: effects of methiothepin and other serotonergic antagonists. Brain Res 1992; 597: 16-23.
24. Luscombe GP, Martin KF, Hutchins LJ, Gosden J, Heal DJ. Mediation of the antidepressant-like effect of 8-OH-DPAT in mice by postsynaptic 5-HT1A receptors. Br J Pharmacol 1993; 108: 669-677.
25. Bacon WL, Beck SG. 5-hydroxytryptamine (7) receptor activation decreases slow after hyperpolarization amplitude in CA3 hippocampal pyramidal cells. J Pharmacol Exp Ther 2000; 294: 672-679.
26. Gradin K, Pettersson A, Hjorth S, Hedmer T, Arvidsson LE, Persson B. Cardiovascular effects in the Sprague-Dawley rat of 8-hydroxyl-2(di-N- propylamino) tetralin, a selective 5-hydroxytryptamine receptors agonist. J Pharm Pharmacol 1985; 37: 263-265.
27. Jackson HC, Griffin IJ, Nutt DJ. Alpha-2-adrenoceptor antagonists block the stimulant effects of cocaine in mice. Life Sci 1992; 50: 155-159.
28. Ieni JR, Thurmond JB. Maternal aggression in mice: effects of treatments with PCPA, 5-HTP and 5-HT receptor antagonists. Eur J Pharmacol 1985; 111: 211-220.
29. Laverty R, Taylor KM. Effects of intraventricular 2, 4, 5-trihydroxyphenyl-ethylamine (6-hydroxydopamine) on rat behavior and brain catecholamine metabolism. Br J Pharmacol 1970; 40: 836.
30. Loscher W, Honack D. The behavioral effects of MK-801 in rats: involvement of dopaminergic, serotonergic and noradrenergic systems. Eur J Pharmacol 1992; 215: 199-208.
31. A Borsini F, Pulvirenti L, Samanin R. Evidence of dopamine involvement in the effect of repeated treatmeht with various antidepressants in the behavioral 'despair' test in rats. Eur J Pharmacol 1985; 110: 253-256.
32. Eison AS, Eison MS, Iveson SD. The behavioral effects of a novel substance P analogue following infusion into the ventral tegmental area of substantia nigra of rat brain. Brain Res 1982; 238: 137-152.
33. Fjalland B, Boeck V. Neuroleptic blockade of the effect of various neurotransmitter substances. Acta Pharmacol Toxicol 1978; 42: 206.
34. Vanderwolf CH, McLauchlin M, Dringenberg HC, Baker GB. Brain structures involved in the behavioral stimulant effect of central serotonin release. Brain Res 1997; 772: 121-134.
35. Mylecharane EJ. Ventral tegmental area 5-HT receptors: mesolimbic dopamine release and behavioral studies. Behav Brain Res 1996; 73: 1-5.